SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-166856
Filing Date
2023-06-14
Accepted
2023-06-14 16:06:54
Documents
12
Period of Report
2023-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d523020d8k.htm   iXBRL 8-K 50577
  Complete submission text file 0001193125-23-166856.txt   175192

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ortx-20230614.xsd EX-101.SCH 2522
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20230614_lab.xml EX-101.LAB 17807
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20230614_pre.xml EX-101.PRE 11187
6 EXTRACTED XBRL INSTANCE DOCUMENT d523020d8k_htm.xml XML 3591
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 231014155
SIC: 2836 Biological Products, (No Diagnostic Substances)